UPDATES ON CLINICAL TRIALS

Sponsored By 

Concurrent Speaker(s)

• 

  Viviane Tabar, MD

  Neurosurgery
  Memorial Sloan Kettering Cancer Center, USA

Presenting Author(s)

• 

  Hideyuki Okano, MD, PhD (he/him/his)

  Keio University Regenerative Medical Research Center
  Keio University, Japan
• 

  Lisa Ott de Bruin, MD, PhD

  Pediatrics and Immunology
  Leiden University Medical Centre, Netherlands
• 

  Sonja Schrepfer, MD, PhD

  Head of Hypo-immune Platform
  Sana Biotechnology, United States
• RS

  Ruchi Sharma

  OGVFB
  NEI/NIH, USA

This session will provide a high-level overview of regenerative medicine efforts by institution and/or organ.

Presentations:

• PHASE I CLINICAL TRIAL OF HUMAN ES-DERIVED DOPAMINE NEURONS GRAFTS FOR PARKINSON'S DISEASE: 18 MONTHS DATA
  

  Concurrent Speaker: Viviane Tabar, MD – Memorial Sloan Kettering Cancer Center
• A PHASE I/IIA TRIAL TO TEST SAFETY AND FEASIBILITY OF AN AUTOLOGOUS IPS CELL-DERIVED RETINAL PIGMENT EPITHELIUM PATCH IN AGE-RELATED MACULAR DEGENERATION PATIENTS
  

  Presenting Author: Ruchi Sharma – NEI/NIH
• LENTIVIRAL GENE THERAPY TO CORRECT RAG1 DEFICIENCY
  

  Presenting Author: Lisa Ott de Bruin, MD, PhD – Leiden University Medical Centre
• FIRST-IN-HUMAN CLINICAL TRIAL OF TRANSPLANTATION OF IPSC-DERIVED NS/PCS IN SUBACUTE COMPLETE SPINAL CORD INJURY: INTERIM REPORT
  

  Presenting Author: Hideyuki Okano, MD, PhD (he/him/his) – Keio University
• HYPOIMMUNE ISLET CELLS MEDIATE INSULIN INDEPENDENCE AFTER ALLOGENEIC TRANSPLANTATION WITHOUT IMMUNOSUPPRESSION
  

  Presenting Author: Sonja Schrepfer, MD, PhD – Sana Biotechnology